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Abstract
During various inflammatory processes circulating cytokines including IL-6, IL-1β, and
TNFα elicit a broad and clinically relevant impairment of hepatic detoxification that is based
on the simultaneous downregulation of many drug metabolizing enzymes and transporter
genes. To address the question whether a common mechanism is involved we treated
human primary hepatocytes with IL-6, the major mediator of the acute phase response in
liver, and characterized acute phase and detoxification responses in quantitative gene
expression and (phospho-)proteomics data sets. Selective inhibitors were used to disentan-
gle the roles of JAK/STAT, MAPK, and PI3K signaling pathways. A prior knowledge-based
fuzzy logic model comprising signal transduction and gene regulation was established and
trained with perturbation-derived gene expression data from five hepatocyte donors. Our
model suggests a greater role of MAPK/PI3K compared to JAK/STAT with the orphan
nuclear receptor RXRα playing a central role in mediating transcriptional downregulation.
Validation experiments revealed a striking similarity of RXRα gene silencing versus IL-6
induced negative gene regulation (rs = 0.79; P<0.0001). These results concur with RXRα
functioning as obligatory heterodimerization partner for several nuclear receptors that regu-
late drug and lipid metabolism.
Author Summary
During inflammation, circulating proinflammatory cytokines such as TNFα, IL-1ß, and
IL-6, which are produced by, e.g., Kupffer cells, macrophages, or tumor cells, play impor-
tant roles in hepatocellular signaling pathways and in the regulation of cellular homeosta-
sis. In particular, these cytokines are responsible for the acute phase response (APR) but
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also for a dramatic reduction of drug detoxification capacity due to impaired expression of
numerous genes coding for drug metabolic enzymes and transporters. Here we used high-
throughput (phospho-)proteomic and gene expression data to investigate the impact of
canonical signaling pathways in mediating IL-6-induced downregulation of drug metabo-
lism related genes. We performed chemical inhibition perturbations to show that most of
the IL-6 effects on gene expression are mediated through the MAPK and PI3K/AKT path-
ways. We constructed a prior knowledge network as basis for a fuzzy logic model that was
trained with extensive gene expression data to identify critical regulatory nodes. Our
results suggest that the nuclear receptor RXRα plays a central role, which was convincingly
validated by RXRα gene silencing experiments. This work shows how computational
modeling can support identifying decisive regulatory events from large-scale experimental
data.
Introduction
In a variety of acute and chronic illnesses, including bacterial or viral infection, tissue injury,
many chronic diseases and most cancers, proinflammatory cytokines such as interleukin (IL)
6, IL-1β, and TNFα evoke a major reorganization of hepatic gene expression resulting in the
massive synthesis of acute phase proteins such as C-reactive protein (CRP) [1]. It has long
been known that under such conditions the drug metabolism capacity and other hepatic func-
tions can be impaired, largely due to strong and broad downregulation of most drug metaboliz-
ing enzymes and transporters (DMET) at the transcriptional level [2–4]. As 60 to 80% of all
used drugs are extensively metabolized in the liver [5], these changes may lead to unrecognized
drug overdosing and adverse events especially for drugs with narrow therapeutic index, includ-
ing many cardiovascular, anti-cancer and central nervous system drugs [6–9]. DMET genes are
regulated at the constitutive level by hepatic nuclear factors (HNF) such as HNF-1α, HNF-4α,
and CCAAT-enhancer binding proteins (C/EBPs) [10,11], while inducible expression involves
several ligand-activated receptors including the aryl hydrocarbon receptor (AhR), the constitu-
tive androstane receptor (CAR), the pregnane X receptor (PXR), the peroxisome proliferator-
activated receptor-α (PPARα) and others, which function as pleiotropic sensors for a large
variety of endogenous and xenobiotic compounds [12,13]. The potential involvement of several
of these transcription factors in the downregulation of DMETs by proinflammatory cytokines
has been suggested in numerous reports on both mouse and human model systems [14–18].
Taken together, current evidence indicates that the downregulation of hepatic DMET genes by
proinflammatory cytokines involves intense crosstalk between signaling components and the
transcriptional machinery, potentially involving several and overlapping receptor-dependent
mechanisms. Some authors also suggested coordinated mechanisms, e.g. involving the major
hepatic retinoid X receptor, RXRα, which is required as a heterodimerization partner for sev-
eral nuclear receptors including CAR, FXR, LXR, PPAR, PXR, and VDR [19,20].
Further upstream, the signaling pathways involved in DMET regulation also remained
largely unclear. IL-6 is known to activate janus kinase/ signal transductors and activators of
transcription (JAK/STAT), mitogen activated protein kinase/ extracellular regulated kinase
(MAPK/ERK), and phosphoinositide 3 kinase (PI3K)/AKT pathways [21,22]. Earlier work has
shown that downregulation of the major human drug metabolizing cytochrome P450,
CYP3A4, in response to IL-6 occurs independently of the JAK/STAT pathway [14], although it
remained unknown whether this also applies to other DMET genes. On the other hand there is
evidence that MAPKs are able to phosphorylate nuclear receptors, which may lead to their
Fuzzy-Logic Modeling of Hepatocyte IL-6 Response
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subcellular relocalization [19,23], and PI3K/AKT may induce nuclear translocation of NF-κB,
which has been shown to antagonize nuclear receptor function by mutual repression as well as
by direct binding of NF-κB to DMET promoter regions [24].
To enhance understanding of the complex interactions within signaling pathways and tran-
scriptional networks, different kinds of systems biology modeling techniques have been
increasingly employed [25–30]. The most prominent types of logical models are Boolean mod-
els, which permit individual components to be only in active or inactive state, thus allowing
only a qualitative description of the input-output behavior of signaling pathways. While very
large Boolean models can be constructed, they are often not adequate for describing biological
reality. By contrast, logic-based ordinary differential equation (ODE) modeling enables a more
quantitative simulation of signaling dynamics over time [27]. However, the requirement for
extensive time-resolved experimental data as well as prior knowledge about the involved sig-
naling mechanisms limits application of ODE modeling to small networks. An intermediate
alternative is provided by “fuzzy logic”, a highly flexible methodology that enables system com-
ponent states to be in a continuous interval. Recent studies have shown that fuzzy logic can be
applied to complex biological problems. Some studies established the use of fuzzy logic to
convert prior (e.g., literature-based) knowledge networks to computable models that can be
trained to multi-factorial experimental data in order to understand complex signaling path-
ways [28–30].
Here we used primary human hepatocytes (PHH) stimulated by IL-6, the most potent medi-
ator of the acute phase response in liver, to characterize cellular responses in high-throughput
quantitative gene expression and (phospho-)proteomics data sets. Using a previously devel-
oped large-scale Boolean model of IL-1 and IL-6 signaling [22] and extensive literature survey
we constructed a fuzzy logic model comprising IL-6 signal transduction and DMET gene regu-
lation. Selective inhibitors used in perturbation experiments to disentangle JAK/STAT, MAPK,
and PI3K signaling pathways generated the necessary data for model training. Our approach
suggests a major role of MAPK and PI3K pathways with the orphan nuclear receptor RXRα at
a central position as link between inflammatory signaling and downregulation of drug detoxifi-
cation genes. We finally validated these findings by RXRα knock-down experiments. This
study emphasizes fuzzy logic modeling as a useful alternative to elucidate complex signaling
interactions.
Results
Construction of a prior knowledge network
We first constructed a prior knowledge network (PKN) comprising IL-6 signal transduction
and downstream gene regulation (S1 Fig). The core of the signal transduction part of the net-
work was taken from the Boolean model by Ryll and colleagues [22], which comprises several
signaling pathways. As we were primarily interested in identifying logical nodes and not in
dynamic features, we did not attempt to include a time scale. This allowed us to simplify the
model by removing feedback loops, including those involving SOCS1 and SOCS3, without neg-
atively impacting our model, because feedback loops by definition require a time scale. Further-
more, we deleted several input and output nodes not relevant for our study. The AND, OR,
and NOT gates of the remaining network were transformed into activating or inhibiting transi-
tions from the respective input species of the gate to the output species. All changes introduced
to the model by Ryll et al. are summarized in S1 Text.
The IL-6 signal transduction module of the PKN was supplemented with a gene regulation
module by compiling biological knowledge from various cell types as provided by databases
and scientific literature, including e.g., BIOBASE TRANSFAC and Pubmed (S2 Text). The
Fuzzy-Logic Modeling of Hepatocyte IL-6 Response
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resulting network contained all DMET genes including their transcriptional regulators STAT3,
NF-κB, AhR, HNF-1α, HNF-4α, ELK1, glucocorticoid receptor, and cFOS, as well as a species
RXR/NR, which represents the complexes between RXRα and any of the nuclear receptors
known to be a potential partner of RXRα.
Phosphoproteomics analysis of IL-6 response pathways in PHH
We used PHHs because these cells are considered the “gold standard”model for the investiga-
tion of hepatic metabolism of drugs and its regulation at the cellular level [31,32]. Despite con-
siderable inter-individual variability and limitations in availability, PHHs are superior to
immortalized cell lines, whose de-regulated cell cycle control is a result of massive changes in
mitogenic and apoptotic signaling, and to primary mouse hepatocytes, whose genomic
response poorly resembles that of humans, especially during an inflammatory response [33]. It
should be pointed out that the limited availability of PHH, their rather short live-span in the
fully differentiated state, and the lack of appropriate cryopreservation protocols preclude the
possibility to perform complete experiments or replications in the same donor. We determined
signaling pathway activation upon IL-6 stimulation in PHH of three independent donors
(donors D1-D3, Table 1) by quantification of a large panel of phosphoproteins using reverse-
phase protein array (RPA) technology (Fig 1A). Among the 32 detected phosphoproteins, con-
sistently induced phosphorylations (i.e. at 10 and 30 min after stimulation) of AKT, c-JUN,
ERK1/2, STAT1, STAT3, and STAT6 were observed, although not all were statistically signifi-
cant (Fig 1B–1E, left panel). Western blot analyses confirmed the RPA findings (Fig 1B–1E,
right panels). Thus, increased phosphorylation of AKT, ERK1/2, STAT1, and STAT3 at their
respective phosphorylation sites was demonstrated, indicating activation of the associated sig-
naling pathways.
Chemical perturbation analysis of IL-6 response pathways in PHH
Gene expression upon IL-6 stimulation was measured after 24 h for major DMET genes as well
as for genes indicating inflammation or activation of a specific pathway (see S1 Table for a list
of all measured genes). We used specific chemical inhibitors to selectively interfere with
STAT3, PI3K, and MAPK signaling as confirmed by RPA measurements (Fig 2). Gene expres-
sion analysis following chemical inhibitions of pathways were conducted in PHH from five
liver donors (donors D4-D8, Table 1). The resulting five gene expression data sets contained
single inhibitions of STAT3, PI3K, and MAPK as well as combinatorial inhibitions of STAT3
Table 1. Overview on hepatocyte donors, treatments, and analyses.
Donor # Age Sex Treatments Analyses Utilisation
D1 75 f IL-6 phosphoproteins (10 + 30 min) signaling pathways
D2 71 f IL-6 phosphoproteins (10 + 30 min) signaling pathways
D3 48 f IL-6 phosphoproteins (10 + 30 min) signaling pathways
D4 59 f IL-6, IL-6 + PI3Ki gene expression (24 h) modeling
D5 47 f IL-6, IL-6 + MAPKi + PI3Ki gene expression (24 h) modeling
D6 29 f IL-6, IL-6 + STAT3i gene expression (24 h) modeling
D7 48 m IL-6, IL-6 + STAT3i + MAPKi gene expression (24 h) modeling
D8 71–80 f IL-6, IL-6 + MAPKi, IL-6 + PI3Ki, IL-6 + STAT3i gene expression (24 h) modeling
D9 21–30 m IL-6, siRXRα gene expression (24 h) validation
D10 41–50 f IL-6, siRXRα gene expression (24 h) validation
D11 70–79 m IL-6, siRXRα gene expression (24 h) validation
doi:10.1371/journal.pcbi.1004431.t001
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Fig 1. Phosphoprotein activation upon IL-6 stimulation in PHH. (A) Heat map showingmean changes (IL-6 vs. control) in levels of 32
phosphoproteins at two time points from three independent PHH donors. Phosphoproteins were detected by RPA with phosphospecific antibodies
directed at the indicated phosphorylation sites. Red color represents positive and blue color negative log2FC (color code provided). Asterisks indicate
statistical significance (P<0.05). (B-E, left panel) Bar charts showing means ± SD (n = 3) of relative fluorescent intensities (RFIs) of selected phosphoproteins
at different time points after IL-6 stimulation. RFIs were obtained from the RPA and background-normalized. Error bars represent standard deviations
calculated from replicates of three donors (not available in E) and asterisks indicate statistical significance (P<0.05). (B-E, right panel) Western blots of total
cell lysate (20 µg each) of selected phosphoproteins from control (Ctrl.) and IL-6 treated cells. β-Actin staining served as loading control. Detection was
performed with an Odyssey infrared imaging system.
doi:10.1371/journal.pcbi.1004431.g001
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+ MAPK and PI3K + MAPK, while the combined inhibition of STAT3 + PI3K rapidly induced
cell death and was therefore not included in the analysis. In agreement with previous observa-
tions, IL-6 elicited a profound transcriptional downregulation of many genes of the drug detox-
ification system.
Hierarchical clustering based on the log 2 linear fold change (log2FC) values shows major
clusters of genes and treatments (Fig 3). One major gene cluster comprises CRP and SOCS3,
which were strongly upregulated, indicating IL-6-dependent activation of the acute phase
response. Except for CYP2E1, all CYPs as well as several important ATP-binding cassette
(ABC) and solute carrier (SLC) transporters were downregulated upon IL-6 stimulation. The
upregulation of CYP2E1 was not seen in all donors, causing a separation from the two other
upregulated genes in the hierarchical clustering. The cluster of treatments shown on the upper
part of Fig 3 consisted of treatments including a MAPK and/or a PI3K inhibitor. Most of the
Fig 2. Overview of IL-6-induced pathways and their inhibition by selective inhibitors. Classically, IL-6 signals through a receptor complex composed of
glycoprotein 130 (gp130) and gp80 (IL-6Rα), or the soluble sIL-6R and activates the Janus kinase (JAK)/signal transducer and activator of transcription
(STAT) pathway. Apart from STAT transcription factors, IL-6 also activates the mitogen activated protein kinase (MAPK)/extracellular regulated kinase 1 and
2 (ERK1/2) (MAPK/ERK)-cascade and the phosphatidyl-inositol-3-kinase (PI3K)-cascade, both through the proximal SHP2 binding phosphotyrosine motif,
leading to activation of AKT serine/threonine kinases. AKTmay then transiently associate with and induce the activation of IκB kinase and thereby activate
the canonical NF-κB pathway. Colors indicate major pathways: PI3K/AKT (blue), JAK/STAT (green), and MAPK (red). The grey box summarizes nuclear
receptors (NRs) and transcription factors responsible for the inducible or constitutive regulation of DMET genes. Arrows indicate positive stimulation or
transcriptional activation, whereas flat-ended arrows indicate inhibition, mutual repression or transcriptional repression. Points of action of chemical pathway
inhibition by LY294002 (PI3K inhibition), Stattic (STAT3 inhibition), and U0126 (MAPK inhibition) are shown by red flat-ended arrows. This figure was
adapted and modified from Eulenfeld et al. [21] and Castellano and Downward [55] using additional primary literature sources (S2 Text). For the complete
PKN please refer to S1 Fig.
doi:10.1371/journal.pcbi.1004431.g002
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IL-6-induced effects were attenuated in this cluster. Single treatments with the STAT3 inhibitor
clustered together with the five IL-6 treatments in the absence of inhibitors, although almost
complete loss of STAT3 pY705 was demonstrated by RPA analysis (see Materials and Meth-
ods). In conclusion, both MAPK and PI3K signaling appeared to play a more important role in
IL-6 induced DMET gene regulation as compared to STAT3.
Construction and application of an optimized fuzzy logic model
We used adapted routines of the R library CNORfuzzy [34] in order to create an optimized
fuzzy logic model from the gene expression data and the prior knowledge network (see Materi-
als and Methods). The model was trained with the five perturbed gene expression data sets that
contained single inhibitions of STAT3, PI3K, and MAPK as well as combinatorial inhibitions
of two pathways (donors D4-D8, Table 1). The resulting model family (Fig 4) illustrates the
connections between signaling molecules and regulated genes quantitatively, with the line
width of each transition representing the percentage of the optimized models (N = 100) con-
taining this particular transition. By far most of the transitions are connected to the RXR/NR
complex species, which represents heterodimeric complexes between RXRα and a number of
nuclear receptors including PXR, FXR, and others [20]. Additional striking nodes that connect
to several regulated genes are identified as NFkB, HNF4A, and HNF1A. For a few genes the
model further suggests the inhibition of the glucocorticoid receptor by MAPK, and inhibition
of AHR by NF-κB. The involved transitions for these events are present in nearly all of the
optimized models (Fig 4).
Fig 3. Heat map of gene expression changes following IL-6 stimulation and chemical inhibitions in
PHHs of five donors (D4-D8; Table 1). Cells were treated for 24h with IL-6 in the absence or presence of
one or two chemical inhibitors (PI3Ki: LY294002; MAPKi: U0126; STAT3i: Stattic; see Table 1 and Materials
and Methods for details). Gene expression was quantified by TaqMan qPCR and fold changes relative to
control (vehicle alone) are shown for 37 genes contained in the model; missing measurements are displayed
in black color. See Materials and Methods for details on heat map construction and hierarchical clustering.
doi:10.1371/journal.pcbi.1004431.g003
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Comparison of the predictions of the model family with the respective data showed marked
agreement for most genes, as indicated by bright-colored fields (Fig 5). Some higher deviations
between prediction and data were seen only for few genes in certain conditions, in particular
SOCS3 and to a lesser extent some DMET genes, e.g. CYP2A6 and CYP2C8, in the presence of
STAT3 inhibitor (darker colored fields). This may indicate unknown regulatory events not
contained in the prior-knowledge network. In the case of SOCS3, the deviations reflect induced
measured levels while the model predicts baseline levels due to the assumed inhibition of
STAT3. Despite confirmed effective STAT3 inhibition (vide supra), we cannot exclude the pos-
sibility that residual activity leads to “leaky” upregulation of SOCS3, since this is one of the
most strongly regulated STAT3 target genes. It should be pointed out that this discrepancy can-
not be due to the missing feedback loop in our model, which precludes secondary effects, as
mentioned above.
Validating the role of RXRα
The optimized fuzzy logic model (Fig 4) suggested an important role of the RXRα/NR com-
plexes. We used siRNA-mediated selective RXRα gene silencing to analyze the impact on gene
expression of major DMET genes via high-throughput real-time qPCR analysis. RXRα protein
expression was almost completely suppressed as demonstrated by Western blot analysis (Fig
6A). Fig 6B illustrates the IL-6- and RXRα knock-down (KD)-induced gene expression changes
in PHH from three independent donors (D9-D11, Table 1). RXRα KD was further confirmed
by more than 90% downregulation of RXRAmRNA. Upon IL-6 stimulation, APR genes were
highly upregulated and a coordinated downregulation of major DMET genes was observed in
all donors, similar to those described for donors D4-D8 (Fig 3). The impact of RXRα KD on
Fig 4. Optimized model family based on the PKN and the gene expression perturbation data. Signaling molecules are displayed in white text on red
background, genes in black text on light red, and AND-nodes in green ovals. Only transitions that are contained in at least 30% of the 100 optimized models
are shown. The line width of each transition represents the percentage of the 100 optimization runs, in which the transition is retained in the model. RXR/NR
denotes heterodimeric complexes between RXRα and various nuclear receptors which maintain transitions to most of the DMET genes. The figure has been
created with Cytoscape [56].
doi:10.1371/journal.pcbi.1004431.g004
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Fig 5. Comparison of the predictions of the optimized PKNwith the respective data points from five gene expression data sets. The normalized data
points are displayed in black solid lines, the predicted points in blue dashed lines. The vertical bars show the standard deviations of the normalized data
points. The columns correspond to the genes, the rows to the different treatments. The figure has been created with an adapted method of CNORfuzzy [34].
doi:10.1371/journal.pcbi.1004431.g005
Fuzzy-Logic Modeling of Hepatocyte IL-6 Response
PLOS Computational Biology | DOI:10.1371/journal.pcbi.1004431 January 4, 2016 9 / 20
expression of DMET and modifier genes was very pronounced with similar patterns compared
to the effects of IL-6. This visual impression was supported by Spearman correlation analysis,
showing a highly significant correlation between the mean fold changes of IL-6 and RXRα KD
treatments (rs = 0.79; N = 86; P<0.0001; Fig 6C). Among the phase I metabolism genes, most
Fig 6. Validation of the role of RXRα in the downregulation of DMET genes by gene silencing in PHH.
(A) Western blot analysis of RXRα in total protein lysates 48 h and 72 h after transfection of cells with siCtrl
(control) and siRXRα. β-Actin staining served as loading control. (B) Heat map showing the relative changes
in gene expression (log2FC) for 86 selected APR and DMET genes after IL-6 stimulation (IL-6 vs. control,
24 h) or after siRNA-mediated KD of RXRα (siRXRα vs. siControl, 72 h) in PHH of three independent donors
(D9-D11, Table 1). Red color represents up- and blue color downregulation according to the supplied color
code. Mean fold changes and statistical analyses of the same data are presented in S3 Fig. (C) Spearman
correlation analysis between mean log2FC values for IL-6 and siRXRα treatments across all genes for all
three donors. The calculated Spearman coefficient was rs = 0.79 (N = 86, P<0.0001).
doi:10.1371/journal.pcbi.1004431.g006
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of which were strongly and significantly downregulated, only CYP2E1 reacted differently,
being downregulated by the RXRα KD while it showed (nonsignificantly) higher levels after
IL-6 treatment. The phase II metabolism genes NAT1, NAT2, and SULT1A1 were also downre-
gulated to similar extent. Of note, the transporters ABCB1 and SLC10A1 showed opposite regu-
lation, being upregulated by RXRα KD and downregulated by IL-6. Among the DMET
modifiers, only AHR, ARNT, and PPARA expression was significantly impaired by IL-6 but not
after the KD of RXRα. As expected, the RXRα KD experiment did not indicate significant
induction of most acute phase genes.
Discussion
In this study we investigated the response of primary human hepatocytes to stimulation with
IL-6, the most potent pro-inflammatory cytokine for the hepatic APR. Using quantitative gene
expression and time-resolved (phospho-)proteomics data sets of unprecedented comprehen-
siveness, we optimized a fuzzy logic model comprising all known major IL-6 signal transduc-
tion pathways as well as a broad spectrum of DMET gene regulation pathways. Our model
suggested a major role of MAPK and PI3K pathways with the orphan nuclear receptor RXRα
playing a central role as link between inflammatory signaling and downregulation of drug
detoxification genes. Experimental RXRα knock-down by RNA interference further substanti-
ated a coordinating role of RXRα to downregulate a wide variety of drug detoxification genes
during inflammation.
Based on our high-throughput (phospho-)proteomic analysis only a few major signaling
molecules demonstrated increased phosphorylation status following IL-6 treatment: AKT
(S473), ERK1/2, (T202/Y204), STAT1, (Y701) and STAT3 (Y705). Whereas activation of
STATs as well as established APR factors and ERK1/2 by IL-6 was shown previously
[21,35,36], increased phosphorylation of AKT at S473 following IL-6 treatment has not been
shown before to our knowledge. Of note, PHH cultures of several donors showed increased
phosphorylation at AKTS473 already at the steady state prior to treatment. This may indicated
drug- or disease-induced basal deregulation of PI3K signaling pathway in the hepatocytes of
these patients [37]. Our chemical inhibitions, which had been confirmed to be effective at the
used concentrations by RPA phosphorylation analysis, indicated that blocking STAT3 signal-
ing pathway compromised the IL-6 effect on DMET mRNA expression only marginally and
only for few DMET genes, in agreement with a previous study showing that STAT3 was not
required for CYP3A4 downregulation [14]. Inhibition of the MAPK and PI3K pathways how-
ever markedly interfered with IL-6-induced DMET expression changes, particularly in combi-
nation (Fig 3). Thus, co-inhibition analyses of PI3K and MAPK as well as of STAT3 and
MAPK signaling pathways abolished almost all IL-6-mediated effects on DMET gene expres-
sion, suggesting a higher relevance of MAPK/PI3K compared to the JAK/STAT pathway in
mediating the IL-6 triggered effects. Some limitations of this approach should be noted. Chem-
ical inhibitors may have unspecific effects [38] and may also activate NRs by themselves [39].
However, we believe that the concentrations used here were low enough to show primarily true
effects on the intended pathways. Furthermore, extensive pathway crosstalk [21] poses general
difficulties in the interpretation of such data.
In order to elucidate the regulatory events responsible for IL-6 regulation of DMET gene
expression, we developed a fuzzy logic model. This modeling technique avoids the requirement
for estimating numerous kinetic parameters as in ODE modeling and allows more realistic
approximations to biological systems compared to simple Boolean logic. Fuzzy logic modeling
has been previously used in studies involving rather tedious manual calibration of model
parameters [28] as well as parameter estimations with heuristic optimization routines [29,30].
Fuzzy-Logic Modeling of Hepatocyte IL-6 Response
PLOS Computational Biology | DOI:10.1371/journal.pcbi.1004431 January 4, 2016 11 / 20
In our study we applied the latter approach due to the lack of prior knowledge about model
parameters. This required training of the model by experimental data. Morris et al. [29] intro-
duced a method to train signal transduction pathways to protein data that we adapted to the
use of gene expression data sets. As we combined several data sets for model training, we con-
structed a “mean”model over these data sets. A principal problem in this respect could be vari-
ability in the gene expression data throughout different donors. However, as shown by our
datasets representing 8 individual donors (Figs 3 and 6), IL-6 effects on both APR and DMET
genes were remarkably similar for all liver donors. In principle, donor-specific models could
have been created by model calibration with respect to only the data for a specific donor. In
order to obtain a reliable model, this would, however, require that all experimental perturba-
tions are conducted in this donor, which is practically very difficult with PHHs.
The model suggested the inhibition of the complexes of RXRα and nuclear receptors by
MAPK and Nf-κB as the major event for the downregulation of most DMET genes by IL-6.
RXRα is required as heterodimerization partner for several important nuclear receptors includ-
ing CAR, FXR, LXR, PPAR, PXR, and VDR [20]. A coordinating role of RXRα based on its bio-
logical function has been previously proposed [19] but only few mouse genes had been
observed in that study and to our knowledge the hypothesis has not been tested for humans.
Here we used siRNA-mediated gene KD in PHH to confirm the model-proposed role of RXRα
in DMET gene downregulation. In three independent donors we observed highly similar pat-
terns of regulation with comparably few interindividual differences (Fig 6), resulting in a highly
significant correlation (rs = 0.79, N = 86; P<0.0001) between mean fold changes elicited by the
two treatments.
Regarding the underlying mechanisms, it had been shown previously that endotoxin leads
to rapid loss of nuclearly localized RXRα, while RXRαmRNA levels were not affected [19],
which is in agreement with our findings (Figs 6 and S3). The detailed molecular events leading
to RXRα inhibition remain to be investigated. Modulation of the phosphorylation status of
nuclear receptors including RXRα has been proposed as a possible event in this process [19].
In conclusion, this study provides new insights into the coordinated negative regulation of
DMET genes by the proinflammatory cytokine IL-6. Using extensive datasets that characterize
the activation of signaling pathways and the regulation of a broad range of APR and DMET
genes in primary human hepatocytes we found that MAPK and PI3K/AKT signaling pathways
appear to be more important than STAT3 signaling in mediating the response of DMET genes
to IL-6. A fuzzy logic model based on gene expression data sets from five different hepatocyte
donors identified RXRα as a key player in downregulation of DMET gene expression, which
was confirmed by gene silencing experiments. While previous fuzzy logic modeling approaches
mainly focused on describing signaling events, our model also involves gene regulation. Hence,
our study is a novel example for the elucidation of key gene-regulatory events from biological
data and prior knowledge using fuzzy logic.
Materials and Methods
Ethics statement
The use of PHH was approved by the local ethics committee and written informed consent was
obtained from all donors (number 025–12, Ethics Committee of the Medical Faculty of the
Ludwig-Maximilians-Universität München).
Reagents
William’s E Medium was purchased from Invitrogen Life Technologies (Darmstadt, Germany).
Fetal bovine serum (FBS) was from PAA Laboratories GmbH (Pasching, Austria), human
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insulin from Sanofi (Frankfurt, Germany), and hydrocortisone from Pfizer Pharma GmbH
(Karlsruhe, Germany). Hepes, L-glutamine, MEM non-essential amino acids (NEAA), penicil-
lin/streptomycin (Pen/Strep), phosphate-buffered saline (PBS), and sodium pyruvate were pur-
chased from GIBCO (Carlsbad, CA, USA). Bovine serum albumin (BSA), dexamethasone, and
dimethyl sulfoxide (DMSO) were from Sigma-Aldrich (Steinheim, Germany), hydrocortisone
from Pfizer (Karlsruhe, Germany). Human recombinant intereukin-6 (IL-6) was purchased
from Promo Cell GmbH (Heidelberg, Germany). Human recombinant interleukin 1β (IL-1β)
and tumor necrosis factor α (TNF α) were purchased from Sigma-Aldrich (Steinheim, Ger-
many). All cytokines were reconstituted and stored as high concentration stocks according to
manufacturer specifications. Chemical inhibitors were purchased from the following suppliers:
LY294002 (Merck, Darmstadt, Germany), U0126 (Promega, Madison, WI, USA), and Stattic
(Sigma-Aldrich, Steinheim, Germany). Inhibitor stock solutions (20 mM each) were prepared
in DMSO. All TaqMan assays were purchased from Applied Biosystems (Foster City, CA,
USA). Silencer Select Pre-designed siRNA was purchased from Applied Biosystems (Foster
City, CA, USA).
Human hepatocyte cultures
PHH were isolated from partial liver resections by collagenase digestion as described previously
[32,40]. Donor data are shown in Table 1. Isolated cells with a viability of more than 70% as
determined via trypan exclusion test were seeded at a density of 4 × 105 viable cells/well onto
BioCoat Collagen I Cellware 12-well culture plates (Becton Dickinson, Bedford, USA) in Wil-
liam’s E Medium, supplemented with 10% FBS, 100 U/ml Pen/Strep, 2 mM L-glutamine,
32 mU/ml human insulin, 1 mM sodium pyruvate, 1X NEAA, 15 mM hepes, and 0.8 μg/ml
hydrocortisone. After 24 h, cells were equilibrated for another 24 h in cultivation medium,
containing William’s E Medium, supplemented with 10% FBS, 100 U/ml Pen/Strep, 2 mM
L-glutamine, 32 mU/ml human insulin, 0.1% DMSO, and 0.1 μM dexamethasone. Cells were
maintained at 37°C in 5% CO2 throughout the experiment with the exception of the shipping
period. All cells were cultured for a minimum of 48 h between isolation and treatment. Media
were changed every 24 h.
Treatments
PHH were treated for up to 24 h with 10 ng/ml human recombinant IL-6 in PBS, supplemented
with 0.1% BSA, or vehicle only (PBS + 0.1% BSA). This concentration had been previously
shown in various cell models to activate STAT3 and to induce CRP expression without being
toxic [41,42]. Furthermore, maximal induction of acute phase protein mRNA expression
including CRP and SAA1/2 was recently demonstrated by dose-response experiments in PHH
[4].
For inhibition of signaling pathways, three specific chemical inhibitors were applied, target-
ing three major signaling proteins: LY294002 for PI3K (upstream of AKT), U0126 for MEK1/2
(upstream of ERK1/2), and Stattic for STAT3. LY294002 was shown to be a potent inhibitor of
PI3K in hepatocytes, where concentrations of> 20 μM inhibited the enzyme’s activity by more
than 90% [43]. U0126 is a selective inhibitor for MEK-1 and -2 [44]. It was shown to effectively
inhibit wild-type MEK1 phosphorylation of ERK2 in concentrations between 20 and 100 μM
in in vitro experiments [45]. Stattic is a selective inhibitor of the activation, dimerization, and
nuclear translocation of STAT3 shown to inhibit STAT3 in vitro with an IC50 value after one
hour of incubation of 5.1 ± 0.8 μM [46]. For inhibition, medium was aspirated and replaced by
fresh medium containing one or a combination of chemical inhibitors in final concentrations
of 10 μM (Stattic) and 50 μM (LY294002 and U0126). DMSO-treated cells served as control.
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After incubation for 1 h, cells were treated with IL-6 or vehicle as described above. Successful
inhibition of signal propagation was assessed in PHH using phosphoproteomics RPA technol-
ogy. IL-6-dependent AKT S473, ERK1/2, and STAT3 Y705 phosphorylation was confirmed to
be nearly abolished by LY294002, U0126, and Stattic, respectively.
KD of RXRα via Silencer Select Pre-designed siRNA (P/N4392420, #s12384; sense:
UCGUCCUCUUUAACCCUGAtt, antisense: UCAGGGUUAAAGAGGACGAtg) was carried
out in PHH according to the manufacturer’s instructions. In short, transfection mix was pre-
pared and after 20 min incubation at RT added, giving a total volume of 1.2 ml per well
(12-well plate).
Quantitative real-time PCR
Total RNA was isolated from PHH and HepaRG cells using the RNeasy Mini Kit, including
on-column genomic DNA digestion with RNase free DNase Set (Qiagen, Hilden, Germany).
The RNA integrity (RIN) and quantity were analyzed with the Agilent 2100 Bioanalyzer using
the RNA 6000 Nano Kit (Agilent Technologies, Waldbronn, Germany). Only samples with a
RIN value larger than 7 were used. Synthesis of cDNA was performed with 500 ng RNA using
TaqMan Reverse Transcription Reagents (Applera GmbH, Darmstadt, Germany). Quantifica-
tion of expression of 95 genes was performed using Fluidigm’s BioMark HD high-throughput
quantitative 96x96 chip platform (Fluidigm Corporation, San Francisco, CA, USA), following
the manufacturer’s instructions [47]. All used predesigned TaqMan assays are listed in S1
Table. The mRNA expression levels were normalized to the most stably expressed gene among
a selection of housekeeping genes (ACTB, GAPDH, GUSB,HMBS, POLR2A, RPLP0, TBP) by
using the Normfinder Excel Add-in as described by Andersen and colleagues [48]. Relative
gene expression changes were calculated using the delta delta Ct (ΔΔCt) method [49]. ΔΔCt
values were calculated by subtracting the ΔCt value of the calibrator sample (e.g., PBS, 0.1%
BSA-treated) from the ΔCt of the experimental sample (e.g., IL-6-treated). As the Ct is on a log
2 scale, linear fold changes (FCs) were calculated as 2(-ΔΔCt).
Quantification of phosphoproteins
RPA technology and Western blot analysis were used for relative quantification of protein
phosphorylations. In the RPA, pL amounts of protein mixtures are immobilized in a microar-
ray format and the presence of specific target proteins is screened by using highly selective anti-
bodies [50]. This technology allows for the simultaneous quantification of more than 100
proteins and phosphoproteins by direct two-step immunoassay using specific primary antibod-
ies [51]. Proteins were isolated using the CLB1 lysis buffer. Sample preparation and measure-
ments were carried out as described elsewhere [51]. Western blots of selected phosphoproteins
and of RXRα were performed with total cell lysate (20 μg of protein). β-Actin staining served as
loading control. Detection was performed with an Odyssey infrared imaging system. Details on
the antibodies used can be found in S2 Table.
Clustering of gene expression data
Each DMET gene is represented by a vector of fold changes for all treatments. The R function
heatmap.2 [52] was used to create a heat map of the genes and treatments based on the loga-
rithmized fold changes. The genes as well as the treatments are thereby clustered hierarchically
with average-linkage clustering using Euclidean metrics [53].
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Fuzzy logic modeling and CNORfuzzy method
CNORfuzzy is an add-on to the CellNOptR, which constructs a fuzzy logic model that enables
the model species to be in a continuous state in the interval [0,1]. A state of 0 for a model spe-
cies then represents inactivity of the species and a state of 1 the highest possible activity. States
in between stand for intermediate activity levels of the species.
This routine has been used with proteomic data [29] and was here applied to gene expres-
sion data. The two discrete states for model species in CellNetOptimizer (CNO) corresponding
to an active and inactive species have proven to be suitable for modeling the activity of signal-
ing molecules [54]. However, for most genes instead of this on-off-pattern, we rather expect a
gene to have several activation states. Therefore, we use CNORfuzzy for creating our model of
IL-6 induced DMET gene regulation. CNORfuzzy first tries to remove from the network all
species that are neither measured nor perturbed in the experimental data, i.e., the only species
that are additionally maintained in the network are those that are necessary for logical consis-
tency. The program then expands the PKN with possible AND-gates to supplement the already
implemented OR-gates. For model inference a genetic algorithm that optimizes the mean
squared error between model prediction and normalized experimental data was used. This
algorithm fits transfer functions for each gate to the data. In the following model reduction
step, gates that do not significantly affect the mean squared error (MSE) between model predic-
tion and data are removed based on a chosen selection threshold that determines the maximum
tolerated increase in the MSE, when a model is reduced by removing logic gates. CNORfuzzy
thus reduces the network to a topology that is sufficient to explain the experimental data.
The genetic algorithm for optimization and the following reduction procedure of CNOR-
fuzzy were run 100 times, resulting in a family of optimized and reduced models. The mean
number of parameters in the optimized model family depends on the chosen selection thresh-
old (S2 Fig). At a selected threshold of 0.01, the average MSE for the 100 models was 0.013 and
the mean number of parameters in the optimized model family was approximately 110. Details
on network compression and optimization are presented in the supplemental S3 Text.
Adaptation of CNO normalization method for gene expression data
The methods of Cell Net Optimizer and CNORfuzzy are based on normalized data in the inter-
val [0,1]. However, our gene expression data have a different structure and the normalization
method is neither suitable for the Ct values, nor for the calculated fold changes. Therefore, we
adapt the given method in order to enable a transformation of the fold change values into the
interval [0,1].
We transformed all fold change values fci of a gene with the following Hill function, which






This Hill function is similar to the Hill function in the CNO routine [54]. The main differ-
ence to the normalization method provided by CNO is the lack of fold change computation in
our approach, because our data already contained fold changes.
The fold change values for genes downregulated by IL-6 are usually smaller than 1 in the
experimental data, whereas for genes upregulated by IL-6 they are greater than 1. In order to
reasonably transform the values into [0,1] for both classes of genes, the midpoint of the Hill
functionm had to be chosen differently. An important aspect to consider for this
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transformation is that model simulation with CNORfuzzy only produces species states of 0 or
1 in the case of inactivity of IL-6 (see S3 Text). Therefore, normalization of gene states for con-
trol treatments should also lead to values near 0 or 1. For all genes downregulated by IL-6, their
gene activity after control treatment must be high compared to after IL-6 treatment and thus
their normalized values should be close to 1. To this end,m was set to 0.5, which proved effec-
tive. For CYP2E1, which is upregulated, we correspondingly setm = 2, because the control
treatments represent a comparably low activity in this case. The other genes upregulated by IL-
6 (SAA, CRP, SOCS3) showed large fold changes upon IL-6 stimulation andm = 2 was not
suitable for their midpoint of the normalization function. Therefore, we setm to half of the
mean fold change value of the IL-6 treatments over the data sets.
For all genes h was set to 4, which led to a transformation of the control fold change values
(1) to a value near 0 (for the genes upregulated by IL-6) or 1 (for the genes downregulated by
IL-6). In this way, we ensured that the transformed data points were spread throughout the
entire interval [0,1]. We also conducted model calibrations with modified values ofm for the
genes downregulated by IL-6. Increasingm led to worse fitting results (MSE of approximately
0.025 form = 0.7), while decreasingm produced fitting results with similar MSE but unsatisfy-
ing spread of the data over the interval [0,1].
Statistical methods
Statistical significance of (phospho)proteomic and gene expression changes was analyzed by
grouped t-test (two-tailed). Spearman correlation coefficients (rs) were calculated for averaged
fold changes from three independent experiments. Statistical significance was defined as
P<0.05. All statistical calculations were performed using GraphPad Prism software (version
5.04; GraphPad Software Inc., San Diego, CA).
Supporting Information
S1 Fig. Prior knowledge network comprising IL-6 signaling and downstream gene regula-
tion. IL-6 signal transduction transitions were taken from the model by Ryll et al. [22]. This
model was simplified by removing feedback loops as well as by deleting irrelevant input and
output nodes (S1 Text). AND, OR, and NOT gates were transformed into simple activating or
inhibitory transitions. We extended the model with signal transduction steps and gene-regula-
tory events based on newer literature (S3 Text). Color code: genes with measured expression
level, black text/light-red ovals; proteins measured by RPA, white text/red ovals; proteins not
measured, white text/grey ovals. The figure was created with Cytoscape [56].
(TIF)
S2 Fig. Reduction curve for model family resulting from optimization of the PKN. The
curve shows how the mean MSE (mean squared error) and the mean number of parameters of
the model family depend on the selection threshold. The chosen setting of the selection thresh-
old of 0.01 lead on average to approximately 110 model parameters. This figure was created
with CNORfuzzy [34].
(TIF)
S3 Fig. Heat map showing mean relative changes in gene expression (log2FC) upon IL-6
stimulation (IL-6 vs. control, 24 h) or siRNA-mediated knock down of RXRα (siRXRα vs.
siControl, 72 h) in PHH of three independent donors (D9-D11; see Table 1 and Fig 6 for
individual donor data). Asterisks indicate statistical significance: , P<0.05; , P<0.01; ,
P<0.005; , P<0.001.
(TIF)
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S1 Table. Predesigned TaqMan assays for quantitative gene expression analysis.
(DOCX)
S2 Table. Antibodies used for Western blot analysis.
(DOCX)
S1 Text. Summary of changes applied to the network by Ryll et al.
(DOCX)
S2 Text. Supplementary references used for compiling biological knowledge to the PKN.
(DOCX)
S3 Text. Detailed description of the CNORfuzzy method.
(DOCX)
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